CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-08-18 | GOLDBERG Y. PAUL VP of Clinical Development | Exercise or conversion · Stock Option (Right to Buy) | −2,057 | 0 | ||
| 2015-06-17 | TARNOW MICHAEL M Director | Exercise or conversion | +1,543 | $4.95 | $8K | 55,167 |
| 2015-06-17 | TARNOW MICHAEL M Director | Exercise or conversion · Stock Option (Right to Buy) | −1,543 | 0 | ||
| 2015-05-21 | GANNON STEVEN Director | Grant or award · Stock Option (Right to Buy) | +5,144 | 5,144 | ||
| 2015-05-04 | TARNOW MICHAEL M Director | Grant or award · Stock Option (Right to Buy) | +3,086 | 3,086 | ||
| 2015-05-04 | TARNOW MICHAEL M Director | Grant or award · Stock Option (Right to Buy) | +1,028 | 1,028 | ||
| 2015-05-04 | PATOU GARY Director | Grant or award · Stock Option (Right to Buy) | +3,086 | 3,086 | ||
| 2015-05-04 | HOLLER FRANK A Director | Grant or award · Stock Option (Right to Buy) | +3,086 | 3,086 | ||
| 2015-05-04 | Hayden Michael R Director | Grant or award · Stock Option (Right to Buy) | +3,086 | 3,086 | ||
| 2015-05-04 | Evans Johnston L Director | Grant or award · Stock Option (Right to Buy) | +3,086 | 3,086 | ||
| 2015-05-04 | AZAB MOHAMMAD Director | Grant or award · Stock Option (Right to Buy) | +3,086 | 3,086 | ||
| 2015-05-04 | SCHELLER RICHARD H Director | Grant or award · Stock Option (Right to Buy) | +3,086 | 3,086 | ||
| 2015-04-30 | STEIN EVAN A. Director | Other disposition | −1,038,964 | 0 | ||
| 2015-04-30 | STEIN EVAN A. Director | Other acquisition | +909,619 | 910,586 | ||
| 2015-04-30 | STEIN EVAN A. Director | Other acquisition | +4,172 | 4,172 | ||
| 2015-03-17 | ROBIN SHERRINGTON SVP Bus. & Corp. Development | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2015-03-17 | PIMSTONE SIMON N. President & CEO | Grant or award · Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2015-03-17 | MORTIMER IAN CFO & COO | Grant or award · Stock Option (Right to Buy) | +55,000 | 55,000 | ||
| 2015-03-17 | GOLDBERG Y. PAUL VP, Clinical Development | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2015-03-17 | CORRAINI KAREN G. Gen. Counsel & Corp. Secretary | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 |
Page 39 of 42 · 836 trades